Logo image of ARMN

ARIS MINING CORP (ARMN) Stock Fundamental Analysis

USA - NYSEARCA:ARMN - CA04040Y1097 - Common Stock

10.07 USD
-0.18 (-1.76%)
Last: 10/10/2025, 9:10:30 PM
10.07 USD
0 (0%)
After Hours: 10/10/2025, 9:10:30 PM
Fundamental Rating

5

Taking everything into account, ARMN scores 5 out of 10 in our fundamental rating. ARMN was compared to 156 industry peers in the Metals & Mining industry. There are concerns on the financial health of ARMN while its profitability can be described as average. ARMN is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ARMN was profitable.
In the past year ARMN had a positive cash flow from operations.
ARMN had positive earnings in 4 of the past 5 years.
ARMN had a positive operating cash flow in each of the past 5 years.
ARMN Yearly Net Income VS EBIT VS OCF VS FCFARMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

With a Return On Assets value of 0.23%, ARMN perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.55%, ARMN is in line with its industry, outperforming 57.69% of the companies in the same industry.
ARMN has a better Return On Invested Capital (8.13%) than 75.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARMN is below the industry average of 12.16%.
The 3 year average ROIC (7.46%) for ARMN is below the current ROIC(8.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.23%
ROE 0.55%
ROIC 8.13%
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)7.46%
ROIC(5y)12%
ARMN Yearly ROA, ROE, ROICARMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

ARMN has a better Profit Margin (0.79%) than 60.90% of its industry peers.
In the last couple of years the Profit Margin of ARMN has declined.
With an excellent Operating Margin value of 31.92%, ARMN belongs to the best of the industry, outperforming 83.97% of the companies in the same industry.
ARMN's Operating Margin has declined in the last couple of years.
ARMN has a better Gross Margin (40.61%) than 78.21% of its industry peers.
In the last couple of years the Gross Margin of ARMN has declined.
Industry RankSector Rank
OM 31.92%
PM (TTM) 0.79%
GM 40.61%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
ARMN Yearly Profit, Operating, Gross MarginsARMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

3

2. Health

2.1 Basic Checks

ARMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ARMN has more shares outstanding
The number of shares outstanding for ARMN has been increased compared to 5 years ago.
ARMN has a better debt/assets ratio than last year.
ARMN Yearly Shares OutstandingARMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ARMN Yearly Total Debt VS Total AssetsARMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.43, we must say that ARMN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.43, ARMN is doing worse than 78.85% of the companies in the same industry.
The Debt to FCF ratio of ARMN is 9.30, which is on the high side as it means it would take ARMN, 9.30 years of fcf income to pay off all of its debts.
ARMN's Debt to FCF ratio of 9.30 is fine compared to the rest of the industry. ARMN outperforms 62.18% of its industry peers.
ARMN has a Debt/Equity ratio of 0.53. This is a neutral value indicating ARMN is somewhat dependend on debt financing.
ARMN has a worse Debt to Equity ratio (0.53) than 79.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.3
Altman-Z 1.43
ROIC/WACC0.9
WACC9.06%
ARMN Yearly LT Debt VS Equity VS FCFARMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

ARMN has a Current Ratio of 2.15. This indicates that ARMN is financially healthy and has no problem in meeting its short term obligations.
ARMN has a Current ratio (2.15) which is comparable to the rest of the industry.
ARMN has a Quick Ratio of 1.85. This is a normal value and indicates that ARMN is financially healthy and should not expect problems in meeting its short term obligations.
ARMN's Quick ratio of 1.85 is in line compared to the rest of the industry. ARMN outperforms 55.13% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.85
ARMN Yearly Current Assets VS Current LiabilitesARMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.13% over the past year.
ARMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -60.21% yearly.
The Revenue has grown by 14.06% in the past year. This is quite good.
The Revenue has been growing by 9.36% on average over the past years. This is quite good.
EPS 1Y (TTM)103.13%
EPS 3Y-60.21%
EPS 5YN/A
EPS Q2Q%237.5%
Revenue 1Y (TTM)14.06%
Revenue growth 3Y10.1%
Revenue growth 5Y9.36%
Sales Q2Q%73.62%

3.2 Future

The Earnings Per Share is expected to grow by 21.96% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.03% on average over the next years. This is a very strong growth
EPS Next Y383.24%
EPS Next 2Y63.85%
EPS Next 3Y58.09%
EPS Next 5Y21.96%
Revenue Next Year44.68%
Revenue Next 2Y47.27%
Revenue Next 3Y33.64%
Revenue Next 5Y21.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARMN Yearly Revenue VS EstimatesARMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ARMN Yearly EPS VS EstimatesARMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.49 indicates a correct valuation of ARMN.
Based on the Price/Earnings ratio, ARMN is valued cheaply inside the industry as 88.46% of the companies are valued more expensively.
ARMN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 10.13, which indicates a very decent valuation of ARMN.
85.90% of the companies in the same industry are more expensive than ARMN, based on the Price/Forward Earnings ratio.
ARMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.57.
Industry RankSector Rank
PE 15.49
Fwd PE 10.13
ARMN Price Earnings VS Forward Price EarningsARMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARMN is valued cheaper than 84.62% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARMN indicates a somewhat cheap valuation: ARMN is cheaper than 77.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.74
EV/EBITDA 7.96
ARMN Per share dataARMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

ARMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ARMN's earnings are expected to grow with 58.09% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y63.85%
EPS Next 3Y58.09%

0

5. Dividend

5.1 Amount

No dividends for ARMN!.
Industry RankSector Rank
Dividend Yield N/A

ARIS MINING CORP

NYSEARCA:ARMN (10/10/2025, 9:10:30 PM)

After market: 10.07 0 (0%)

10.07

-0.18 (-1.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.72B
Analysts81.82
Price Target12.09 (20.06%)
Short Float %1.61%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.81%
Min EPS beat(2)-17.28%
Max EPS beat(2)-6.35%
EPS beat(4)0
Avg EPS beat(4)-23.44%
Min EPS beat(4)-45.53%
Max EPS beat(4)-6.35%
EPS beat(8)0
Avg EPS beat(8)-33.09%
EPS beat(12)1
Avg EPS beat(12)-32.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-3.93%
Revenue beat(4)0
Avg Revenue beat(4)-4.5%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-3.93%
Revenue beat(8)0
Avg Revenue beat(8)-4.57%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.58%
PT rev (3m)23.96%
EPS NQ rev (1m)-4%
EPS NQ rev (3m)-9.43%
EPS NY rev (1m)0%
EPS NY rev (3m)122.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.49
Fwd PE 10.13
P/S 2.66
P/FCF 30.74
P/OCF 6.65
P/B 1.85
P/tB 1.85
EV/EBITDA 7.96
EPS(TTM)0.65
EY6.45%
EPS(NY)0.99
Fwd EY9.88%
FCF(TTM)0.33
FCFY3.25%
OCF(TTM)1.51
OCFY15.03%
SpS3.78
BVpS5.44
TBVpS5.44
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.23%
ROE 0.55%
ROCE 10.3%
ROIC 8.13%
ROICexc 9.62%
ROICexgc 9.62%
OM 31.92%
PM (TTM) 0.79%
GM 40.61%
FCFM 8.66%
ROA(3y)0.71%
ROA(5y)4.01%
ROE(3y)1.68%
ROE(5y)8.18%
ROIC(3y)7.46%
ROIC(5y)12%
ROICexc(3y)9.42%
ROICexc(5y)16.26%
ROICexgc(3y)9.42%
ROICexgc(5y)16.26%
ROCE(3y)9.44%
ROCE(5y)15.19%
ROICexcg growth 3Y-31.05%
ROICexcg growth 5Y-33.95%
ROICexc growth 3Y-31.05%
ROICexc growth 5Y-33.95%
OM growth 3Y-13.31%
OM growth 5Y-7.27%
PM growth 3Y-53.75%
PM growth 5YN/A
GM growth 3Y-11.09%
GM growth 5Y-5.36%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.3
Debt/EBITDA 2.01
Cap/Depr 504.9%
Cap/Sales 31.34%
Interest Coverage 3.93
Cash Conversion 104.9%
Profit Quality 1101.51%
Current Ratio 2.15
Quick Ratio 1.85
Altman-Z 1.43
F-Score6
WACC9.06%
ROIC/WACC0.9
Cap/Depr(3y)395.74%
Cap/Depr(5y)328%
Cap/Sales(3y)29.9%
Cap/Sales(5y)24.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.13%
EPS 3Y-60.21%
EPS 5YN/A
EPS Q2Q%237.5%
EPS Next Y383.24%
EPS Next 2Y63.85%
EPS Next 3Y58.09%
EPS Next 5Y21.96%
Revenue 1Y (TTM)14.06%
Revenue growth 3Y10.1%
Revenue growth 5Y9.36%
Sales Q2Q%73.62%
Revenue Next Year44.68%
Revenue Next 2Y47.27%
Revenue Next 3Y33.64%
Revenue Next 5Y21.03%
EBIT growth 1Y0.83%
EBIT growth 3Y-4.56%
EBIT growth 5Y1.41%
EBIT Next Year71.71%
EBIT Next 3Y31.28%
EBIT Next 5Y17.24%
FCF growth 1Y208.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y414.28%
OCF growth 3Y20.56%
OCF growth 5Y6.46%